The University of Chicago Header Logo

Connection

Yasmin Hasan to Doxorubicin

Back to Details
This is a "connection" page, showing publications Yasmin Hasan has written about Doxorubicin.
Yasmin Hasan
Connection Strength
0.036
Doxorubicin
  1. CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial. Lancet Haematol. 2018 May; 5(5):e190-e200.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.